Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data

BACKGROUND: Indacaterol is an inhaled, once-daily long-acting β(2)-agonist bronchodilator for regular use in patients with chronic obstructive pulmonary disease (COPD). As indacaterol is the first once-daily β(2)-agonist to be developed, it is relevant to evaluate its bronchodilator efficacy, safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleecker, Eugene R, Siler, Thomas, Owen, Roger, Kramer, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186741/
https://www.ncbi.nlm.nih.gov/pubmed/22003288
http://dx.doi.org/10.2147/COPD.S21073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186741/
https://www.ncbi.nlm.nih.gov/pubmed/22003288
http://dx.doi.org/10.2147/COPD.S21073

Ejemplares similares